PRECISION
LOCALIZED
THERAPY
For many cancer therapies, often less than 1% of a systemically administered drug reaches the tumor site. KINETIX uses machine learning to optimize scaffold architecture and deliver therapy precisely where disease lives.
A broken system.
Measured in lives and dollars.
Low Bioavailability
Most systemically administered therapies are metabolized or diluted before reaching the target tissue, forcing higher doses that amplify side effects and increase patient risk.
Systemic Toxicity
Drugs flood healthy tissue alongside disease sites, forcing clinicians to choose between therapeutic efficacy and patient safety, a compromise KINETIX eliminates.
Uncontrolled Release
Conventional formulations offer no programmable control over release timing or concentration, an irreducible structural constraint on precision medicine.
Structure-driven control.
Precision delivery at the site of disease.
Localized Delivery
Millimeter-scale scaffolds implanted directly at the site of disease, maximizing local drug concentration while eliminating the systemic exposure that causes toxicity and side effects.
Programmable Release
Drug release profiles engineered into the physical architecture of each scaffold. Therapy timing, duration, and concentration governed through structure, not chemistry alone.
Patient-Specific Design
Machine learning simultaneously optimizes over 14 internal geometry properties to each patient's therapeutic profile, and generates a matched hydrogel loading mold alongside the scaffold, enabling personalized drug delivery at clinical scale without manual engineering overhead.
Biomaterials as precision instruments.
Beyond Chemistry
Traditional drug delivery relies on chemical formulation to modulate release. KINETIX controls release through geometry, through physical architecture that determines how and when therapeutics diffuse into surrounding tissue.
Structure Equals Function
Over 14 internal geometry properties, including porosity, channel architecture, and surface topology, are resolved at millimeter-scale precision and directly determine release performance. The scaffold is not a container. The scaffold is the delivery mechanism.
Design-Driven Precision
Scaffold architectures generated and refined by machine learning to hit precise therapeutic targets. Performance is not approximated through trial and error. It is designed, validated, and delivered with predictive accuracy.
Real scaffolds. Real biology.
Validated performance.
What this means in practice.
Fewer treatment cycles required to achieve therapeutic targets
Significantly reduced systemic toxicity burden on patients
More consistent and reproducible treatment outcomes
Lower effective dosage and lower cost of therapy
One platform.
Multiple therapeutic frontiers.
Oncology
Implantable scaffolds deliver chemotherapy directly at the tumor site. Therapeutic concentrations maximized at the target while systemic drug load, and its associated toxicity, is dramatically curtailed.
Neuroregeneration
Neuroprotective and regenerative agents released precisely at sites of stroke injury or peripheral nerve damage, providing a sustained therapeutic environment that systemic delivery cannot replicate.
Cardiac Repair
Following myocardial infarction, scaffolds release growth factors on a controlled timeline, supporting tissue recovery and reducing the chronic remodeling that leads to heart failure.
Orthopedic Healing
Bone-integrated scaffolds deliver antibiotics, growth factors, or regenerative agents precisely at fracture or implant sites, reducing infection risk while accelerating recovery.
Wound Healing
Programmable release of growth factors and bioactive compounds enables clinicians to tune therapeutic timing and concentration to individual patient healing profiles.
Tissue Engineering
Scaffolds engineered to replicate the structural complexity of native extracellular matrix enable cell-driven tissue repair, extending KINETIX into the full scope of regenerative medicine.
Working on a different indication? Let's discuss your clinical application.
See KINETIX generate a precision scaffold in real time.
Clinical goals in. Machine learning optimizes over 14 geometry properties. Validated scaffold and matched hydrogel loading mold out.
Ready to see it for your indication?
Schedule a briefing tailored to your therapeutic application.
Breakthrough efficacy.
Accessible economics.
Ultra-Low Material Cost
$0.20 – $0.25 per scaffold. A precision drug delivery system at the cost of a pill.
<$8 Total Production
End-to-end fabrication of millimeter-scale scaffolds with high-precision 3D printing, covering materials, printing, and processing, under $8 per scaffold.
Scalable Manufacturing
3D printing compatibility means production scales with demand. Clinical volume is an operational challenge, not a technical one.
Global Clinical Access
Cost efficiency makes precision localized delivery viable beyond elite academic medical centers, across health systems worldwide.
Start a conversation.
Advance the science.
Clinical partnership, research collaboration, or investment: we want to hear from you.
Prefer a direct conversation?
Submit the form and indicate your interest. We will follow up within 1-2 business days to arrange a call with the right member of our team.